Author | Rabiya Tuma, Ph.D.


ESMO: Cisplatin-Navelbine Duo Shows Survival Edge in NSCLC

October 06, 2006

ISTANBUL, Turkey -- Cisplatin-Navelbine (vinorelbine) reduced mortality in fully resected non-small cell lung cancer (NSCLC), according to a meta-analysis reported here.

ESMO: Radiation Plus Hormone Therapy Is Prostate Cancer Plus

October 06, 2006

ISTANBUL, Turkey -- Progression-free survival is prolonged by 10% in men with locally advanced prostate cancer who receive both radiation and hormone therapy, according to a large meta-analysis.

ESMO: Blood Test May Screen for Lung Cancer

October 03, 2006

ISTANBUL, Turkey -- A blood test may be able to distinguish between a malignancy in the lung and a benign pulmonary pathology, researchers reported here.

ASCO: New Drug Class Triggers Tumor Cell Death

June 04, 2006

ATLANTA ? With a new class of drugs, researchers are on the trail of killer receptors on the surface of cancer cells.